Journal of Ophthalmic and Optometric Sciences

Vol. 9 No. 2 (2025)

Optic Neuritis Visual Loss after Intragastric Botulinum Toxin A Injection: A Case Report

Journal of Ophthalmic and Optometric Sciences, Vol. 9 No. 2 (2025), 5 April 2025 , Page 57-60

Abstract

Intragastric botulinum toxin A is increasingly used as an endoscopic adjunct for weight reduction, and although generally safe, rare neurological and ophthalmic adverse effects have been reported. We describe the case of a 37-year-old woman who developed dimming of vision in the left eye twelve days after intragastric botulinum toxin A injection. Visual evoked potential revealed delayed P100 latency in the affected eye, while the contralateral eye was normal, and magnetic resonance imaging demonstrated inflammation of the left optic nerve. Demyelinating disease was excluded through appropriate investigations. The close temporal relationship between botulinum toxin exposure and symptom onset, along with the absence of alternative etiologies, supported a diagnosis of toxin-related optic neuritis. This case highlights that intragastric botulinum toxin A may rarely precipitate optic nerve involvement and emphasizes the importance of patient counseling and prompt ophthalmologic assessment when visual symptoms occur.

Keywords:
  • Botulinum Toxins
  • Intragastric
  • Optic Neuritis
  • Visual Evoked Potentials
  • Obesity
  • Adverse Effects

How to Cite

Shushtarian, S. M. M., Jamshidi, G., Mohammad-Rabei, H., Shojaei, A., & Eslami Vaghar , M. (2025). Optic Neuritis Visual Loss after Intragastric Botulinum Toxin A Injection: A Case Report. Journal of Ophthalmic and Optometric Sciences, 9(2), 57–60. Retrieved from https://journals.sbmu.ac.ir/basir/article/view/50682

References

- Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29(S1):S3-14.

- Moore JM, Haemer MA, Fox CK. Lifestyle and pharmacologic management before and after bariatric surgery. Semin Pediatr Surg. 2020;29(1):150889.

- Arabpour E, Golmoradi H, Tape PMK, Sadeghi A, Abdehagh M, Moghadam PK, et al. Intragastric botulinum toxin injection for weight loss: current trends, shortcomings and future perspective. Clin Endosc. 2025;58(1):10-24.

- Witmanowski H, Błochowiak K. The whole truth about botulinum toxin - a review. Postepy Dermatol Alergol. 2020;37(6):853-61.

- Allahdady F, Aghazadeh Amiri M, Shushtarian SM, Tabatabaee Seyed M, Sahraei F, et al. Comparison of Visual Evoked Potential and Electro-oculogram Tests in Early Detection of Hydroxychloroquine Retinal Toxicity. Journal of Ophthalmic and Optometric Sciences. 2016;1(1):19-26.

- Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology. 2015;95(1-2):65-9.

- Park SH, Park CY, Shin YJ, Jeong KS, Kim NH. Low Contrast Visual Evoked Potentials for Early Detection of Optic Neuritis. Front Neurol. 2022;13:804395.

- Khalili MR, Hosseini S, Shirvani M, Sadati MS. Optic Neuropathy following Botulinum Toxin Injection into the Medial Rectus Muscle for Diplopia. J Ophthalmic Vis Res. 2022;17(2):296-302.

- Chun BY, Kim SY. Acute visual loss after botulinum toxin A injection in the masseter muscle. Int Ophthalmol. 2018;38(3):1339-42.

  • Abstract Viewed: 67 times
  • pdf Downloaded: 52 times

Download Statastics

Current Issue